EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multifaceted therapeutic potential of saponins in type 2 diabetes mellitus: mechanisms targeting insulin resistance and diabetic complications

Yuan Yuan, Ke-Ying Shou, Si-Qi Wu, Jing-Yu Zhao, Yao Liu, Ya-Jun Wang, Hua-Song Luo, Wen-Ting Dai

Frontiers in Pharmacology · 07.05.2026 · 17

DOI: 10.3389/fphar.2026.1793697 ↗

Auf einen Blick

Die Übersichtsarbeit fasst die therapeutischen Potenziale von Saponinen bei Typ-2-Diabetes mellitus zusammen. Beschrieben werden mehrfache antidiabetische Wirkmechanismen und Schutzwirkungen bei Diabeteskomplikationen.

Fragestellung

Welche pharmakologischen Mechanismen und welches therapeutische Potenzial haben Saponine bei T2DM und seinen Komplikationen?

Methode

Systematische Übersichtsarbeit über molekulare, zelluläre, tierexperimentelle und klinische Studien; Literatur bis 2025 aus PubMed, Web of Science und CNKI.

Ergebnisse

Saponine beeinflussen u. a. Keap1/Nrf2, AMPK/PI3K/Akt und NF-κB. Berichtet werden organbezogene Schutzwirkungen bei Nephropathie, Kardiomyopathie, Neuropathie und Retinopathie.

Schlussfolgerung der Autor:innen

Saponine stellen eine potenziell wirksame bioaktive Stoffklasse mit multi-target therapeutischem Potenzial für T2DM und seine Komplikationen dar.

Kernaussagen

  • Mehrere antidiabetische Signalwege werden durch Saponine moduliert.
  • Berichtet werden Schutzwirkungen bei mehreren Diabeteskomplikationen.
  • Die Autoren sehen Vorteile gegenüber Single-Target-Therapien.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.05.2026. Verfasst von Yuan Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder that poses management challenges due to the limited efficacy and adverse effects of current therapies. Saponins, a class of bioactive phytochemicals widely distributed in medicinal plants and other natural sources, exhibit antidiabetic activities through multi-target mechanisms, have emerged as promising therapeutic candidates for T2DM. This review systematically summarizes the pharmacological mechanisms and therapeutic potential of saponins in management of T2DM and its complications. Materials and methods Studies involving molecular, cellular, animal, and clinical studies of saponins in T2DM and its complications were screened and analyzed to provide a systematic overview. All the literature information in this review was collected from relevant literature published up to 2025 from the scientific databases, including PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI).

Results

The pathogenesis of T2DM is characterized by insulin resistance, β-cell dysfunction, genetic susceptibility, gut microbiota dysbiosis, and metabolic disturbances, leading to hyperglycemia and systemic complications. This review demonstrates that saponins exert multifaceted antidiabetic effects through modulating key signaling pathways, including Keap1/Nrf2, AMPK/PI3K/Akt, and NF-κB. Furthermore, saponins demonstrate significant organ-specific protection against major diabetic complications, such as nephropathy, cardiomyopathy, neuropathy, and retinopathy.

Conclusion

Saponins represent a potent class of bioactive metabolites with multi-target therapeutic potential for T2DM and its complications. Their ability to simultaneously modulate metabolic, inflammatory, oxidative, mitochondrial, and gut microbiota-related pathways highlights clear advantages over single-target therapies. A growing body of research has underscored its potential clinical significance in T2DM, providing essential evidence for developing effective and safe therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

diabetic complicationsinsulin resistanceorgan protectionsaponintype 2 diabetes mellitus

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
  • Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Deqing, Zhejiang, China.
  • Key Laboratory for Green Pharmaceutical Technology and Equipment (Zhejiang University of Technology) of Ministry of Education, Deqing, Zhejiang, China.
  • State Key Laboratory of Green Chemical Synthesis and Conversion, Hangzhou, Zhejiang, China.
  • Department of Traditional Chinese Medicine Massage, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.

Zitieren

APA

Yuan, Y., Shou, K. Y., Wu, S. Q., Zhao, J. Y., Liu, Y., Wang, Y. J., Luo, H. S., & Dai, W. T. (2026). Multifaceted therapeutic potential of saponins in type 2 diabetes mellitus: mechanisms targeting insulin resistance and diabetic complications. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1793697

Vancouver

Yuan Y, Shou KY, Wu SQ, Zhao JY, Liu Y, Wang YJ, et al. Multifaceted therapeutic potential of saponins in type 2 diabetes mellitus: mechanisms targeting insulin resistance and diabetic complications. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1793697

BibTeX
@article{Yuan2026,
  author = {Yuan, Yuan and Shou, Ke-Ying and Wu, Si-Qi and Zhao, Jing-Yu and Liu, Yao and Wang, Ya-Jun and Luo, Hua-Song and Dai, Wen-Ting},
  title = {Multifaceted therapeutic potential of saponins in type 2 diabetes mellitus: mechanisms targeting insulin resistance and diabetic complications},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1793697}
}
Kostenlos starten →